Ep Wealth Advisors, LLC Spero Therapeutics, Inc. Transaction History
Ep Wealth Advisors, LLC
- $12 Billion
- Q1 2025
A detailed history of Ep Wealth Advisors, LLC transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Ep Wealth Advisors, LLC holds 16,500 shares of SPRO stock, worth $11,220. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,500Holding current value
$11,220% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SPRO
# of Institutions
43Shares Held
18.4MCall Options Held
9.3KPut Options Held
100-
Anson Funds Management LP Dallas, TX7.64MShares$5.19 Million1.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$1.2 Million0.0% of portfolio
-
Atlas Venture Associates Ix, LLC Boston, MA1.35MShares$920,24614.54% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny971KShares$660,2160.0% of portfolio
-
Alphabet Inc. Mountain View, CA890KShares$605,1850.06% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $23.8M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...